Treatment of superficial basal cell carcinomas and multiple actinic keratoses by French dermatologists: A prospective medical cost analysis;Évaluation médico-économique de la prise en charge des carcinomes basocellulaires superficiels et des kératoses actiniques multiples par les dermatologues français

Annales de Dermatologie et de Venereologie

Volumn 134, Issue 6-7, 2007, Pages 527-533

  Bernard, P ^a   Dupuy, A ^b   Brun, P ^c   Sasko, A ^d   Duru, G ^e   Nicoloyannis, N ^f   Decuypere, L ^g   Grob, J J ^h  

^a SERVICE DE DERMATOLOGIE   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c Cabinet de Dermatologie   (France)

^d CIRC   (France)

^e UNIVERSITÉ LYON 1   (France)

^f UNIVERSITÉ LUMIÈRE LYON 2   (France)

^g 3M COMPANY   (United States)

^h HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; FLUOROURACIL; IMIQUIMOD;

ACTINIC KERATOSIS; AGED; ARTICLE; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CLINICAL TRIAL; CONTROLLED STUDY; CRYOTHERAPY; DIAGNOSTIC TEST; FEMALE; FOLLOW UP; FRANCE; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; SEX DIFFERENCE; SURGICAL TECHNIQUE; TISSUE SECTION; TUMOR BIOPSY; COST BENEFIT ANALYSIS; ECONOMICS; HEAD; HEALTH CARE COST; NECK; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDER; PRACTICE GUIDELINE; PROSPECTIVE STUDY; QUESTIONNAIRE; SKIN TUMOR; SUNLIGHT; THORAX;

AGED; CARCINOMA, BASAL CELL; COST-BENEFIT ANALYSIS; CRYOTHERAPY; FEMALE; FRANCE; HEAD; HEALTH CARE COSTS; HUMANS; MALE; NECK; PHOTOCHEMOTHERAPY; PHOTOSENSITIVITY DISORDERS; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; QUESTIONNAIRES; SKIN NEOPLASMS; SUNLIGHT; THORAX;

EID: 34547767667     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(07)89263-5     Document Type: Article

References (29)

1. Bernard P, Derancourt C, Arnoult-Coudoux E, Picot R, Delvincourt C. Étude prospective des cancers cutanés dépistés en pratique dermatologique dans la région Champagne-Ardenne. Ann Dermatol Venereol 2001;128:883-7.
2. Smith ES, Feldmann SR, Fleischer AB Jr, Leshin B, McMichael A. Characteristics of office visits for skin cancer. Dermatologists have more experience than other physicians in managing malignant and premalignant skin conditions. Dermatol Surg 1998;24:981-5
3. Scrivener Y, Chebil F, Cribier B. Epidémiologie des carcinomes basocellulaires. Ann Dermatol Venereol 2005;132:378-83.
4. Halna JM, Grandadam M, Buemi A. Étude épidé miologique des cancers cutanés basée sur la population d'un département français de 1988 à 1996 : résultats du registre du Haut-Rhin. Nouvelles Dermatologiques 2000;19:48-55.
5. Brisson C, Buré E, Chatal M, Daviet V, Hadet-Riegert M, Humeau, et al. Les carcinomes en Vendée en 2002. Étude prospective. Comparaison avec une précédente étude prospective faite en 1992. Nouvelles Dermatologiques 2003;22:486-7.
6. ANAES. Carcinome basocellulaire : recommandations pour la pratique clinique (ANAES 2004). Ann Dermatol Venereol 2004;131:669-79.
7. Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. The development of actinic keratosis into invasive squamous cell carcinomas:evidence and evolving classification schemes. Clin Dermatol 2004;22:189-96.
8. Higashi MK, Veenstra DL, Langley PC. Health economic evaluation of non-melanoma skin cancer and actinic keratosis. Pharmacoeconomics 2004;22:83-94.
9. Mc Cormack CJ, Kelly JW, Dorevitch AP. Differences in age and body site distribution of the histological subtypes of basal cell carcinoma. Arch Dermatol 1997;133:593-6.
10. Scrivener Y, Grosshans E, Cribier B. Variations of basal cell carcinomas according to gender, age, location and histopathological subtype. Br J Dermatol 2002;147:41-7.
11. Collins GL, Nickoonahand N, Morgan MB. Changing demographics and pathology of non melanoma skin cancer in the last 30 years. Sem Cutan Med Surg 2004;23:80-3.
12. Walther U, Kron M, Sander S, Sebastian G, Sander S, Peter RU, et al. Risk and protective factors for sporadic basal cell carcinoma:results of a two-centre case-control study in southern Germany. Clinical actinic elastosis may be a protective factor. Br J Dermatol 2004;151:170-8.
13. Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma:study of a series of 1039 consecutive neoplasm. J Am Acad Dermatol 1990;23:1118-26.
14. Avril MF, Auperin A, Margulis A, Gerbaulet A, Duvillard A, Benhamou E, et al. Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomised study. Br J Cancer 1997;76:100-6.
15. Telfer NR, Colver GB, Bowwers PW, British Association of Dermatologists. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999;141:415-23.
16. National Health Medical Research Council. Non melanoma skin cancer: guidelines for treatment and management in Australia. Clinical Practice Guidelines. Canberra: NHMRC; 2002.
17. Basal and squamous cell skin cancer guideline. In: The complete Library of NCCN Clinical Practice Guidelines in Oncology, version 1.2005 Jenkintwon, Pa: National Comprehensive Cancer Network. May 2005.
18. Smeets NWJ, Krekels GAM, Ostertag JU, Essers BAB, Dirksen CD, Nieman FHM, et al. Surgical excision vs Mohs'micrographic surgery for basal-cell carcinoma of the face: randomised controlled trial. Lancet 2004;364:1766-72.
19. Rubin AI, Chen EH, Ratner D. Basal cell carcinoma. N Engl J Med 2005;353:2262-9.
20. Bath-Hextall F, Bong J, Perkins W, Williams H. Interventions for basal cell carcinoma of the skin: systematic review. Br Med J 2004;329:705-8.
21. Halpern AC, Hanson LJ. Awareness of knowledge of and attitudes to nonmelanoma skin cancer (NMSC) and actinic keratosis (AK) among physicians. Int J Dermatol 2004;43:638-42.
22. Feldman SR, Fleisher AB, Williford PM, Jorizzo JL. Destructive procedures are the standard of care for treatment of actinic keratoses. J Am Acad Dermatol 1999;40:43-7.
23. Dinehart SM. The treatment of actinic keratoses. J Am Acad Dermatol 2000;42:25-8.
24. Jeffes EWB, Tang EH. Actinic keratoses. Current treatment options. Am J Clin Dermatol 2000;1:167-79.
25. Ortonne JP. From actinic keratosis to squamous cell carcinoma. Br J Dermatol 2002;146 (suppl):20-3.
26. Warino L, Tusa M, Camacho F, Teuschler H, Fleischer AB Jr, Feldman SR. Frequency and costs of actinic keratosis treatment. Dermatol 2006;32:1045-9.
27. Housman TS, Feldmann SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, Chen GJ. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003;48:425-9.
28. Joseph AK, Mark TL, Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 2001;27:955-9.
29. Housman TS, Williford PM, Feldman SR, Teuschler HV, Fleischer AB Jr, Goldman ND, et al. Nonmelanoma skin cancer: an episode of care management approach. Dermatol Surg 2003;29:700-11.